CWNM News 0.0205 05/08/2014 04:39:57 Crown Marketing (CWNM)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Crown Marketing (CWNM) 0.0205 $CWNM

Direct Energy Revenue Up 28% in 2013
PR Newswire - Thu Feb 20, 1:15AM CST
Direct Energy, North America's largest competitive energy and energy-related services company, today announced gross revenue for the full year 2013 of US $11.4 billion (£7.3 billion), an increase of 28 percent, and an operating profit of US$436 million (£276 million). Direct Energy is the North American subsidiary of Centrica plc (LSE: CNA). Centrica reported full year 2013 revenues of US$41.6 billion (£26.6 billion) with an operating profit of US$4.2 billion (£2.7 billion).

Demand Outlook for T&D Electrical Equipment Market in India - Transformer, Switchgear & Energy Meters
PR Newswire - Fri Feb 14, 11:00AM CST
Research and Markets (http://www.researchandmarkets.com/research/77j8t4/demand_outlook) has announced the addition of the "Demand Outlook for T&D Electrical Equipment Market in India - Transformer, Switchgear & Energy Meters" report to their offering.

Osun Court Sentences Two to Death By Hanging for Raping Teenager to Death
All Africa Global Media - Fri Feb 14, 3:36AM CST
An Osogbo High Court on Wednesday sentenced two young men to death by hanging for raping a 14-year-old girl, Bilikisu Adeyemi, to death.

YRC Worldwide Successfully Closes $300 Million Debt Reduction
GlobeNewswire - Fri Jan 31, 3:08PM CST
-- Raises $250 Million of New Equity

Best Practices: Remote Patient Monitoring Projects in Central and Eastern Europe
PR Newswire - Thu Jan 16, 9:32AM CST
Reportbuyer.com just published a new market research report:

Crown Marketing to Develop Oxycontin and Opioid Abuse Resistant Drug Device
Marketwire - Mon Jul 01, 7:00AM CDT
Crown Marketing, Inc. (OTCQB: CWNM) is pleased to announce that it is developing a tamper resistant oxycodone product based on its novel, patented Controlled Drug Delivery Device (CDDT).

Crown Marketing Diet Supplements Debut With Record Breaking 85% Reorder Rate
Marketwire - Fri May 31, 6:31AM CDT
Crown Marketing, Inc. (OTCQB: CWNM) is pleased to announce that consumers have responded with unprecedented enthusiasm to Crown's signature specialty items -- Raspberry Ketones and Green Been Coffee Extract. In response to their recent unveiling, first time buyers who signed up for trial orders re-purchased the items at a shocking 85% re-order rate.

Crown Marketing Files Provisional Patent Application for Diet Supplement
Marketwire - Thu May 30, 6:37AM CDT
Crown Marketing (OTCQB: CWNM) is pleased to announce that it has filed a provisional patent application with the United States Patent and Trademark Office for a unique and novel dietary supplement.

Crown Marketing Kicks Off Million Dollar Advertising Campaign for Nutraceutical Weight Loss Products
M2 - Wed May 15, 8:28AM CDT
Crown Marketing (OTCQB: CWNM) is pleased to announce that its subsidiary, Crown Nutraceuticals has issued a one million dollar purchase order with media firm Rhodium Inc. Rhodium, a full scale global agency, with over 1.3 billion impressions since 2011, will be coordinating Crown's Nutraceuticals campaign for its diet products featuring Raspberry Ketone and Green Bean Coffee Extract. These two popular supplements are widely recognized to be safe and effective treatments for weight loss. Crown anticipates positive revenue growth as a result of this aggressive marketing campaign.

Leading Active Companies in the News: Crown Marketing (CWNM), Nuvilex (NVLX), Elite Pharmaceuticals (ELTP), Cannabis Science (CBIS), Merck (MRK)
ACCESSWIRE-TNW - Thu May 09, 8:11AM CDT
Leading Active Companies in the News: Crown Marketing (CWNM), Nuvilex (NVLX), Elite Pharmaceuticals (ELTP), Cannabis Science (CBIS), Merck (MRK)

Crown Marketing Signs New Agreement for Medical Marijuana Financing Deal
ACCESSWIRE-TNW - Thu May 09, 7:45AM CDT
Crown Marketing Signs New Agreement for Medical Marijuana Financing Deal

Crown Marketing Taps 100 Million Dollar Fund for Medical Marijuana
Marketwire - Thu May 09, 7:00AM CDT
Crown Marketing Inc. (OTCQB: CWNM) is pleased to announce that Crown has signed an agreement with a 100 million dollar fund to provide medical marijuana producers with financing for their commercial real estate needs. Crown will conduct these operations through a wholly owned subsidiary, Joint Venture Solutions Inc. ("Company" .

Crown Marketing to Establish Medical Marijuana Subsidiary
M2 - Wed May 08, 8:45AM CDT
CHAPEL HILL, NC, May 08, 2013 -- Crown Marketing Inc. (OTCQB: CWNM) is pleased to announce that it has formed a wholly owned subsidiary, a Colorado corporation, known as "Joint Venture Solutions, Inc." ("JVS" or "Company" .

Crown Marketing to Launch Nutraceuticals Products Line
Marketwire - Wed Apr 24, 9:38AM CDT
Crown Marketing (OTCQB: CWNM) is pleased to announce that its subsidiary, Crown Nutraceuticals, Inc. will launch their first nutraceuticals and supplements product line anticipating sales to begin within the next thirty days.

Crown Marketing to Establish Nutraceuticals Subsidiary
Marketwire - Tue Apr 23, 7:03AM CDT
Crown Marketing (OTCQB: CWNM) is pleased to announce that it has established a nutraceuticals subsidiary to be known as Crown Nutraceuticals, Inc. Crown Nutraceuticals will engage in the development, manufacturing and marketing of popular nutraceuticals and supplements.

Top Active Companies to Watch: Crown Marketing, Herbalife, Novogen, GNC, Pfizer and Infinity Pharmaceuticals
PR Newswire Europe - Wed Feb 20, 8:11AM CST
CORAL SPRINGS, Florida, February 20, 2013 /PRNewswire/ --

Crown Marketing Patents Approved in Mexico
Marketwire - Wed Feb 20, 7:02AM CST
Crown Marketing (OTCQB: CWNM) is pleased to announce that patents for its Controlled Drug Delivery Technology (CDDT) have been approved and registered in Mexico.

Leading Pharmaceutical Companies Mid-day Trading with Mixed Results and also New Patent News Announced for Crown Marketing
PR Newswire Europe - Thu Feb 14, 1:13PM CST
CORAL SPRINGS, Florida, February 14, 2013 /PRNewswire/ --
Scroll down for more posts ▼

Top 10 Most Recent News Articles

ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 183

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading
Moon Base Ambitions: Impulse Space Wins Key NASA Contracts

Updated Category News Views 742

NASA's Vision and Impulse's New Role Ever think you'd see a company like Impulse Space set to play a starring role in humanity's return to the lunar surface? Well, strap in because this isn't just a pipe dream anymore. NASA's bold plan to establish a Moon Base has taken a tangible step forward with Impulse winning two hefty task orders. This ain't just peanuts—this duo...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 235

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
Fibocom LTE Modules Test Drive Satellite Connectivity

Updated Category News Views 63

Boosting IoT with Satellite Connectivity Here's a good one for folks watching the edge of wireless innovation. Fibocom's LTE Cat.1 bis modules, the LE270-EU and LE271-GL, just stretched their legs in New Zealand, connecting seamlessly with SpaceX's Direct to Cell (DTC) satellite system. No fancy hardware swaps, just standard firmware strutting its stuff across satellite...

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 437

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 209

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 256

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 222

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 490

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 221

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading

Top 5 Most Recently Viewed Articles

Marina Genova Joins SEA Index to Promote Sustainable Yachting

Updated Category News Views 173

Marina Genova Enters SEA Index as an Institutional Member Recently, the Superyacht Eco Association – SEA Index welcomed Marina Genova, a prominent destination for yachting in the Mediterranean, as an Institutional Member. This collaboration signifies a crucial step in the yachting community's commitment to integrating environmental sustainability into its operations....

Continue Reading
Warren Buffett’s Top 2025 Stock Picks You Need to Know

Updated Category News Views 2610

Warren Buffett’s Strategic Stock Investments for 2025 Warren Buffett, the Oracle of Omaha, is known for his keen investment strategies and ability to recognize value in both good and bad market conditions. In the current volatile landscape, his portfolio continues to evolve, with some old favorites and new bets that show his forward-thinking approach. As we look ahead...

Continue Reading
Graves' Ophthalmopathy Market Surges with New Therapies

Updated Category News Views 50

Unexpected Growth in Graves' Ophthalmopathy Market Over the next decade, we're seeing the Graves' ophthalmopathy market gearing up for some serious growth, clocking in at a hefty compound annual growth rate of 9%. A good chunk of this is thanks to Viridian's newest player, LUMVOA, getting the green light, sending competitors scrambling and pushing innovation into...

Continue Reading
Tris Pharma Launches ONYDA XR: A New ADHD Liquid Solution

Updated Category News Views 210

So back in 2024, Tris Pharma rolled out ONYDA™ XR—this liquid medication aimed at tackling ADHD in kids six and older. It was billed as a game changer, especially since the FDA gave it the green light. The desks were buzzing about this first-of-its-kind non-stimulant therapy, positioning it like a golden ticket for parents tired of conventional stimulants that might...

Continue Reading
JPMorgan Updates Price Target for W. P. Carey to $70

Updated Category News Views 242

JPMorgan Boosts W. P. Carey's Price Target Recently, JPMorgan has refreshed its price target for W. P. Carey & Co. (NYSE: WPC), raising it from $68.00 to $70.00, while retaining an Overweight rating on the stock. This adjustment comes ahead of the company’s third-quarter earnings announcement, indicating the firm's confidence in W. P. Carey’s future potential....

Continue Reading